1. Home
  2. CBL vs PHAR Comparison

CBL vs PHAR Comparison

Compare CBL & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBL & Associates Properties Inc.

CBL

CBL & Associates Properties Inc.

HOLD

Current Price

$48.00

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.11

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBL
PHAR
Founded
1978
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CBL
PHAR
Price
$48.00
$13.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$45.00
$38.33
AVG Volume (30 Days)
213.3K
12.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
4.00%
N/A
EPS Growth
132.09
N/A
EPS
1.48
N/A
Revenue
$578,373,000.00
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
$32.71
$3,041.22
Revenue Growth
12.18
N/A
52 Week Low
$24.33
$9.54
52 Week High
$49.18
$21.34

Technical Indicators

Market Signals
Indicator
CBL
PHAR
Relative Strength Index (RSI) 65.24 40.26
Support Level $36.41 $12.98
Resistance Level $48.64 $13.44
Average True Range (ATR) 1.45 0.45
MACD 0.00 0.13
Stochastic Oscillator 71.58 65.80

Price Performance

Historical Comparison
CBL
PHAR

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: